Assessing Skin of Color

Assessing skin of color before a peel means scoring the Fitzpatrick phototype and then deliberately looking past it. Phototype is the backbone of risk stratification, but in Fitzpatrick IV–VI it under-captures the variable that actually drives complications — melanocyte lability, the tendency of pigment cells to over-respond to inflammation with post-inflammatory hyperpigmentation (PIH). A complete assessment layers reactivity, baseline pigment, scarring history and prior peel response on top of the phototype to set a realistic, safe depth ceiling.

Why Fitzpatrick alone under-captures risk

The Fitzpatrick scale was built to predict sunburn and tanning response to UV, not pigmentary response to a controlled chemical injury. It does both jobs only loosely. Two patients can both be Fitzpatrick V and behave completely differently: one tolerates a glycolic series with no marking, the other develops PIH from a mosquito bite. The scale captures how dark the skin is; it does not capture how reactive the melanocytes are.

In Indian practice this matters acutely, because much of the patient base clusters in Fitzpatrick IV–VI yet spans a wide range of reactivity, sun behaviour and baseline pigment patterns. Treating "Fitzpatrick V" as a single risk category will over-treat the tolerant patient and, more dangerously, under-prepare the labile one. The phototype tells you which side of the risk curve you are on; it does not place the individual patient on it.

The individual-typology angle

A more useful mental model is to assess the individual rather than the category. Beyond the phototype number, three readable signals refine where a given patient sits:

• Constitutive vs facultative pigment. Compare a sun-protected site (inner upper arm) with the face. A large gap signals a UV-responsive, tan-prone melanocyte population — a marker of lability.
• Reactivity history. How does the skin respond to everyday insults? Marks after threading or waxing, lingering brown after acne or an insect bite, a darkening rather than reddening response to friction — all point to a melanocyte system that converts inflammation into pigment readily.
• Baseline dyschromia. Existing melasma, periorbital pigmentation or uneven tone tells you the canvas is already pigment-active and that any inflammatory peel will be working against a primed system.

These observations do more practical work than the Fitzpatrick number alone, because they describe the behaviour you are trying to predict.

History that changes the plan

A focused history surfaces the factors that lower the safe ceiling. Ask specifically about:

Domain	What to ask	Why it changes the plan
PIH history	Has acne, eczema or injury left brown marks that lasted months?	Confirms melanocyte lability — the central peel risk in IV–VI
Keloid / hypertrophic scarring	Any raised scars from ear-piercing, surgery, acne?	Heightens caution; favour superficial depth, avoid aggressive injury
Melasma	Pattern, triggers, hormonal/pregnancy link, prior flares	Melasma is easily aggravated by overly inflammatory peels
Photoexposure	Daily sun, two-wheeler commute, outdoor work	UV is the dominant modifiable PIH driver
Prior procedures	Lasers, peels, microneedling — and how the skin responded	Past response predicts future response better than anything else

Prior peel response is the best single predictor

If a patient has been peeled before, their previous response is the most informative datum you can obtain — more reliable than phototype, more reliable than any score. A patient who took a 35% glycolic series with no marking is telling you their melanocytes are comparatively stable; one who developed two weeks of PIH after a single gentle peel is telling you to drop the intensity and lengthen the priming. Always ask, and where possible, look at photographs. In a treatment-naïve patient, a small test spot of the intended agent in a concealed area is the closest substitute for this information.

Baseline pigment and barrier documentation

Before any acid touches the skin, document the baseline objectively. Standardised, well-lit photography (and, where available, the brown/pigment channel of a skin-imaging device) gives you a reference against which to judge later change — and protects both patient and clinician when a transient post-peel darkening is mistaken for a complication. Assess barrier status at the same time: a compromised or over-exfoliated barrier penetrates more deeply and unpredictably, raising the inflammatory load for any given protocol.

Translating the assessment into a ceiling

The assessment converges on a single decision: how deep can you safely go, and how cautious must the agent be? In Fitzpatrick IV–VI the answer is almost always superficial to carefully-titrated medium depth, on primed skin, built across a series — with the more labile, more pigment-active, more scar-prone patients pushed further toward the conservative end. The assessment is not paperwork; it is the instrument that sets that ceiling before you ever pick an acid.

Key takeaway

Score the Fitzpatrick type, then refine it with reactivity, baseline pigment, scarring and PIH history, and above all prior peel response. In skin of color the phototype opens the assessment — melanocyte lability decides it. Get this right and the rest of the protocol (priming, agent choice, depth, photoprotection) follows logically.